Title of article :
Human endogenous retroviruses and chosen disease parameters in morphea
Author/Authors :
Kowalczyk, Michał J. Department of Dermatology and Venereology - Poznan University of Medical Sciences, Poland , Dańczak-Pazdrowska, Aleksandra Unit of Noninvasive Diagnostics of Skin Diseases - Department of Dermatology - Poznan University of Medical Sciences, Poland , Szramka-Pawlak, Beata Department of Dermatology - Poznan University of Medical Sciences, Poland , Żaba, Ryszard Department of Dermatology and Venereology - Poznan University of Medical Sciences, Poland , Osmola-Mańkowska, Agnieszka 4Psoriasis and Novel Therapies Unit - Department of Dermatology - Poznan University of Medical Sciences, Poland , Silny, Wojciech Department of Dermatology - Poznan University of Medical Sciences, Poland
Abstract :
Introduction
Morphea (localized scleroderma) is a relatively rare disease characterized by excessive skin fibrosis. Human endogenous retroviruses (HERV) are largely distributed within the human genome with hundreds of thousands of elements. The HERV have been widely studied in autoimmune disorders, yet hardly ever assessed in diseases with a good prognosis such as morphea.
Aim
In this study we focus on the possible relations between the expression of chosen HERV and factors influencing the pathomechanism of the disease, such as age, sex, titres of anti-nuclear antibodies, as well as duration, activity, and severity of the disease (LoSSI index).
Material and methods
Real-time polymerase chain reaction (PCR) targeting six HERV sequences of interest were performed on samples derived from peripheral blood mononuclear cells (PBMC) and skin biopsies.
Results
In PBMC we found a statistically significant negative correlation between HERV-W env expression and LoSSI index (p = 0.01). Additionally, HERV-W env was downregulated in patients with the active form of morphea. In all other cases we found no correlation whatsoever nor statistically significant differences below the p = 0.05 threshold.
Conclusions
Morphea seems to be an autoimmune disease where the impact of HERV is not so apparent. It seems that probing many patients for the expression of just a few sequences is not as effective as previously expected. For initial studies of HERV in other diseases we recommend high throughput techniques such as HERV-dedicated DNA microarrays or massive parallel sequencing.
Keywords :
human endogenous retroviruses , real-time polymerase chain reaction , autoimmunity , localized scleroderma , skin
Journal title :
Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii